[1] |
CALDWELL CC, TSCHOEP J, LENTSCH AB, et al. Lymphocyte function during hepatic ischemia/reperfusion injury[J]. J Leukoc Biol, 2007, 82(3): 457-464. doi: 10.1189/jlb.0107062
|
[2] |
SHEN X, WANG Y, GAO F, et al. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury[J]. Hepatology, 2009, 50(5): 1537-1546. DOI: 10.1002/hep.23153.
|
[3] |
CALDWELL CC, OKAYA T, MARTIGNONI A, et al. Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion[J]. Am J Physiol Gastrointest Liver Physiol, 2005, 289(5): G969-G976. doi: 10.1152/ajpgi.00223.2005
|
[4] |
REIFART J, RENTSCH M, MENDE K, et al. Modulating CD4+ T cell migration in the postischemic liver: hepatic stellate cells as new therapeutic target?[J]. Transplantation, 2015, 99(1): 41-47. DOI: 10.1097/TP.0000000000000461.
|
[5] |
MAGGI U, FORNONI G, CENTONZE L, et al. Ischemia time and liver transplantation, today[J]. Transplant Proc, 2014, 46(7): 2295-2299. DOI: 10.1016/j.transproceed.2014.07.040.
|
[6] |
HAGA H, YAN IK, BORRELLI DA, et al. Extracellular vesicles from bone marrow-derived mesenchymal stem cells protect against murine hepatic ischemia/reperfusion injury[J]. Liver Transpl, 2017, 23(6): 791-803. DOI: 10.1002/lt.24770.
|
[7] |
ROWART P, ERPICUM P, DETRY O, et al. Mesenchymal stromal cell therapy in ischemia/reperfusion injury[J]. J Immunol Res, 2015: 602597. DOI: 10.1155/2015/602597.
|
[8] |
UCHIDA Y, FREITAS MC, ZHAO D, et al. The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury[J]. Transplantation, 2010, 89(9): 1050-1056. DOI: 10.1097/TP.0b013e3181d45a98.
|
[9] |
VAN GOLEN RF, REINIERS MJ, VRISEKOOP N, et al. The mechanisms and physiological relevance of glycocalyx degradation in hepatic ischemia/reperfusion injury[J]. Antioxid Redox Signal, 2014, 21(7): 1098-1118. DOI: 10.1089/ars.2013.5751.
|
[10] |
ZWACKA RM, ZHANG Y, HALLDORSON J, et al. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver[J]. J Clin Invest, 1997, 100(2): 279-289. doi: 10.1172/JCI119533
|
[11] |
YAO Z, PAINTER SL, FANSLOW WC, et al. Human IL-17: a novel cytokine derived from T cells[J]. J Immunol, 1995, 155(12): 5483-5486. http://www.jimmunol.org/content/155/12/5483.full.pdf
|
[12] |
KONO H, FUJⅡ H, OGIKU M, et al. Role of IL-17A in neutrophil recruitment and hepatic injury after warm ischemia-reperfusion mice[J]. J Immunol, 2011, 187(9): 4818-4825. DOI: 10.4049/jimmunol.1100490.
|
[13] |
KOJIMA N, SATO M, SUZUKI A, et al. Enhanced expression of B7-1, B7-2, and intercellular adhesion molecule 1 in sinusoidal endothelial cells by warm ischemia/reperfusion injury in rat liver[J]. Hepatology, 2001, 34(4 Pt 1): 751-757. doi: 10.1053/jhep.2001.27804?scrollTo=references
|
[14] |
TAKADA M, CHANDRAKER A, NADEAU KC, et al. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury[J]. J Clin Invest, 1997, 100(5): 1199-1203. doi: 10.1172/JCI119632
|
[15] |
LENTSCH AB. Regulatory mechanisms of injury and repair after hepatic ischemia/reperfusion[J]. Scientifica (Cairo), 2012: 513192. DOI: 10.6064/2012/513192.
|
[16] |
FEISST V, BROOKS AE, CHEN CJ, et al. Characterization of mesenchymal progenitor cell populations directly derived from human dermis[J]. Stem Cells Dev, 2014, 23(6): 631-642. DOI: 10.1089/scd.2013.0207.
|
[17] |
徐土炳, 李莉, 罗兴迪, 等.骨髓间充质干细胞在肝细胞损伤恢复中的作用[J].实用医学杂志, 2017, 33(5): 687-692. DOI: 10.3969/j.issn.1006-5725.2017.05.004.XU TB, LI L, LUO XD, et al. Role of bone marrow mesenchymal stem cells in recovery process of hepatocyte injury[J]. J Pract Med, 2017, 33(5): 687-692. DOI: 10.3969/j.issn.1006-5725.2017.05.004.
|
[18] |
ROSSIGNOL J, BOYER C, THINARD R, et al. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation[J]. J Cell Mol Med, 2009, 13(8B): 2547-2558. DOI: 10.1111/j.1582-4934.2009.00657.x.
|
[19] |
唐飞龙, 栾佐, 吴南海, 等.脐带间充质干细胞治疗儿童移植相关并发症的疗效观察[J].转化医学杂志, 2017, 6(3): 132-136. DOI: 10.3969/j.issn.2095-3097.2017.03.002.TANG FL, LUAN Z, WU NH, et al. Therapeutic effect of umbilical cord-mesenchymal stem cell on transplantation-related complications in children[J]. Translat Med J, 2017, 6(3): 132-136. DOI: 10.3969/j.issn.2095-3097.2017.03.002.
|
[20] |
BLOOM DD, CENTANNI JM, BHATIA N, et al. A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression[J]. Cytotherapy, 2015, 17(2): 140-151. DOI: 10.1016/j.jcyt.2014.10.002.
|
[21] |
DANCHUK S, YLOSTALO JH, HOSSAIN F, et al. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6[J]. Stem Cell Res Ther, 2011, 2(3): 27. DOI: 10.1186/scrt68.
|
[22] |
HSU WT, LIN CH, CHIANG BL, et al. Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-γ+CD4+ regulatory T cells to control transplant arteriosclerosis[J]. J Immunol, 2013, 190(5): 2372-2380. DOI: 10.4049/jimmunol.1202996.
|